ArticleOncogene2017
The RB-IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity.
S Kitajima et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it
ArticleOncogene2017
S Kitajima et al.PubMed ↗Publisher ↗
No numbers read from the abstract.